Kaivan Talachian holds a doctorate in pharmacy (Pharm. D) and is a practicing pharmacist in Ontario with more than 25 years of diverse experience in pharmaceutical, medical devices, and healthcare information technology. He has been involved in research, education, and innovation.
He has developed and published educational materials and has conducted numerous presentations in Canada and internationally. He was vice president of professional services at CannTrust until 2019; before that, he was the vice president of healthcare products at NexJ Systems, a publicly-traded Canadian company. In this role, he directed the development and design of a patient-centric software solution to activate and educate patients, collaborate care, and improve medication adherence.
Kaivan managed the development and implementation of integrated medication management and nursing medication verification solutions pioneered at West Park hospital in Toronto, Canada. This solution was subsequently implemented in the United States and acquired by Baxter Pharmaceuticals. Kavain’s five-year work with Baxter global Infusion systems contributed to developing strategy and requirements for the next generation of intelligent infusion systems. In addition, he contributed to the application of several patents in Canada, the US, and the European Union.
Kaivan has worked in different capacities for major pharmacy groups, such as Shoppers Drug Mart, Loblaw, and Costco. He has trained many pharmacists and pharmacy technicians and has been a member of the peer review panel at Hospital Pharmacy Journal. He has collaborated in the clinical heart health study, evaluating the impact of pharmacist interventions on the patient’s clinical outcomes and robotic technology implementation for medication fulfillment.
Kaivan was one of the founding members and past president of the Iranian Canadian Pharmacists Association and a founding member and the executive director of Hami Canada, a not-for-profit organization focused on providing educational opportunities in deprived global regions.
Farhang Modaresi is a bio-entrepreneur with more than 15 years of global experience in the life-science industry. Farhang has an extensive background in planning and managing interdisciplinary projects to commercialize novel life-science technologies. He is a critical thinker who effectively partners with internal and external stakeholders to assess opportunities, design sustainable strategic roadmaps, and drives successful implementations.
Farhang’s ability to evaluate complex topics and strategic design solutions emphasizes his ability to communicate pragmatic solutions for complex healthcare challenges with different clients inside and outside the healthcare sector. Commercialization, strategic management, business development, and complex data analysis are his area of expertise.
Before Concinto, Farhang was the director of clinical services at CannTrust and led a team of 7 clinical consultants. This team delivered the highest growth in independent patient acquisition and sales.
Farhang has contributed to developing the overall strategy for the education of healthcare practitioners on Medical Cannabis and the development of an evidence-based educational curriculum for healthcare practitioners. He has educated more than 1000 Canadian Healthcare practitioners (MDs, Pharmacists, and Nurses) on the medicinal use of cannabis and cannabinoids.
Farhang has been a lead contributor to the development and design of 3 double-blind placebo-controlled clinical trials on medical cannabis. He was also involved in cross-functional product innovation projects.
Before joining CannTrust, he worked as a consultant for a market access consulting firm in Sweden. He advised medical device manufacturers on the best strategies to enter the UK market. Before that, he was a First Line Sales Manager in Novartis and oversaw the commercialization of cardiology, respiratory, and rheumatology product lines for Novartis in Iran.
He holds an MD degree from Mashhad University of Medical Sciences and received his master’s degree in Bio-Entrepreneurship from Karolinska Institute, Stockholm, Sweden, and his certificate in “Canadian Business Management” from York University, Toronto, Ontario.